ClinicalTrials.gg
Not yet recruitingNCT07476989Updated Mar 17, 2026

Effects of Dual-Source Carbohydrate Intake and Liver Glycogen Repletion After Overnight Fasting.

An interventional study of No breakfast and Breakfast (0% Fructose) in Carbohydrate Metabolism, Hepatic Glycogen Storage and Healthy Adult Male, sponsored by Manchester Metropolitan University. Not yet recruiting. Open to male participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-17.

Sponsored by Manchester Metropolitan University · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Male
01

Study summary

This study is looking at whether eating a breakfast which has two different sources of carbohydrates, glucose and fructose (found in foods like honey and fruits), can increase how much glycogen can be stored in the liver. Glucose is a type of sugar that the body uses to provide energy during exercise. When it is not circulating in the blood, it is stored in the muscles and liver. The stored version of glucose is often referred to as glycogen. When the body needs energy, for example, it will break down glycogen into glucose so that it can be used as fuel.

Muscle and liver glycogen stores are vital in providing energy during prolonged exercise, and strenuous activity can rapidly deplete these stores, leading to increased fatigue and a decline in performance. Liver glycogen, however, is particularly important because it controls blood glucose levels. This is important because the brain and other organs are constantly relying on the supply of glucose to function properly.

When sleeping, the body goes through a natural period of fasting. During this period, the liver gradually breaks down its glycogen stores to release glucose into the bloodstream. Because of this, following sleep, liver glycogen stores are automatically low (which is why having breakfast is important). There is research to suggest that eating a high-carbohydrate breakfast can prevent further declines in liver glycogen; however, it is not known if eating different types of carbohydrates within the breakfast (glucose and fructose together) will affect the liver's ability to store glycogen. This research will aid in understanding optimal ways to increase liver glycogen stores before performing exercise, which may influence exercise performance.

Therefore, the main aim of this study is:

1. Investigate whether a high fructose breakfast will increase liver glycogen storage

To achieve this, participants will be recruited to complete a randomised crossover study where they will undertake three different conditions. All laboratory trials will take place at the Manchester Metropolitan University Institute of Sport.

  1. No breakfast (Control)
  2. 3 g/kg of body mass of carbohydrate (of which contains 0% fructose)
  3. 3 g/kg of body mass of carbohydrate (of which contains50% fructose)

Liver glycogen stores will be measured using magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS). The investigators will measure liver glycogen content, liver volume, and stomach volume. Blood samples will also be taken to measure different metabolic hormone responses.

Read the detailed description

Glycogen stores in the muscle and liver play a crucial role in providing fuel during prolonged exercise and strenuous activities, which can rapidly deplete these stores, leading to increased fatigue and reduced performance. During prolonged exercise, liver glycogen is broken down to maintain blood glucose (sugar) levels and provide an important fuel source for the exercising muscles. Accordingly, liver glycogen is important for our ability to perform prolonged endurance exercise.

Following sleep, the body is placed under a natural period of fasting; because of this, the body's main source of fuel derives from liver glycogen stores, meaning hepatic glycogen stores decline sufficiently during this period. Accordingly, without sufficient pre-exercise carbohydrate intake, athletes begin training or competition with reduced liver glycogen availability, which can impair their ability to maintain blood glucose during prolonged exercise and may result in hypoglycaemia and subsequent fatigue. Whilst current guidelines suggest that pre-exercise carbohydrate intake may support the replenishment of depleted liver glycogen stores, it is currently unclear whether the composition of carbohydrates contained within the breakfast meal may impact the ability of the liver to store glycogen.

Fructose is primarily metabolised in the liver and enters hepatic carbohydrate metabolism downstream to key regulatory steps in glycolysis. Research has shown that fructose preferentially contributes to hepatic glycogen storage and, when co-ingested with glucose, enhances post-exercise hepatic glycogen synthesis when compared with glucose alone. Despite this, the effects of fructose within a high-carbohydrate breakfast following overnight fasting (where the metabolic and hormonal environment is markedly different) remain unknown.

As such, the present study aims to assess 1) the effect of a high-carbohydrate breakfast diet on liver glycogen storage and 2) the effect of fructose content on liver glycogen storage.

To achieve our aims, participants will complete three experimental conditions in a randomised, counterbalanced order: 1) no breakfast (control), 2) high carbohydrate breakfast (3 g/kg of body mass) (0% fructose), and 3) high carbohydrate breakfast (3 g/kg of body mass) (50% fructose). Hepatic glycogen concentrations will be quantified using non-invasive 13C magnetic resonance spectroscopy (MRS), with magnetic resonance imaging (MRI) used to assess liver volume and gastric volume. Secondary measures will include circulating metabolic and hormonal responses assessed via venous blood sampling. Primary and secondary outcomes will be compared across conditions to determine whether fructose co-ingestion alters hepatic glycogen storage relative to glucose intake and fasting. This study will provide mechanistic insight into the role of fructose in promoting hepatic glycogen synthesis.

02

Conditions studied

  • Carbohydrate Metabolism
  • Hepatic Glycogen Storage
  • Healthy Adult Male

Keywords

  • Glucose
  • Fructose
  • Liver glycogen storage
  • Magnetic resonance spectroscopy
03

In context

Lead sponsor

Manchester Metropolitan University is the lead sponsor of 19 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • A male (at birth) aged between 18 and 45.
  • Regularly training for a specific sport (must include cycling) at least 3 times per week (with the purpose of competing).
  • VO2 peak >50 (ml.kg.min)
  • A current non-smoker/vaper (must not have smoked or vaped within the last 6 months)
  • Do not have any medical conditions or are taking any medications or supplements which can affect the study's outcome measures.
  • Free from any metallic implants, including permanent jewellery (that can't be removed)
  • No known intolerances or allergies to any component of the nutritional supplement

Exclusion criteria

Exclusion Criteria:

  • Are not a male (at birth) aged between 18 and 45.
  • Do not regularly train for a specific sport (must include cycling) at least 3 times per week (with the purpose of competing).
  • Does not have a VO2 max/peak >50 (ml.kg.min)
  • A current smoker/vaper (must not have smoked or vaped within the last 6 months)
  • Have any medical conditions or are taking any medications or supplements which can affect the study's outcome measures
  • Have any metallic implants, including permanent jewellery (that can't be removed)
  • Known intolerances or allergies to any component of the nutritional supplement.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Control

    No breakfast

    Dietary Supplement: No breakfast

  • Experimental
    0% fructose

    Breakfast containing 0% fructose

    Dietary Supplement: Breakfast (0% Fructose)

  • Experimental
    50% fructose

    Breakfast containing 50% fructose

    Dietary Supplement: Breakfast (50% fructose)

Interventions

  • Dietary supplementNo breakfast

    Participants will come in and receive no breakfast, which will act as a control group.

  • Dietary supplementFructoseStudies of FructoseFructose pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Participants will receive a breakfast of 3g/kg of body mass of carbohydrate with 0% fructose content.

  • Dietary supplementFructoseStudies of FructoseFructose pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Participants will receive a breakfast of 3g/kg of body mass of carbohydrate with 50% fructose content.

06

What researchers measure

Primary outcomes

  1. Change in liver glycogen content

    The change in liver glycogen content will be determined using 13C magnetic resonance spectroscopy

    Time frame: 3 hours

Secondary outcomes

  1. Total carbohydrate oxidation

    Total carbohydrate oxidation will be measured using indirect calorimetry

    Time frame: 3 hours

  2. Total fat oxidation

    Total fat oxidation will be measured using indirect calorimetry

    Time frame: 3 hours

  3. Stomach volume

    Stomach volume will be measured using MRI

    Time frame: 3 hours

  4. Plasma glucose

    Measured via blood collection

    Time frame: 3 hours

  5. Plasma lactate

    Measured via blood collection

    Time frame: 3 hours

  6. Plasma insulin

    Measured via blood collection

    Time frame: 3 hours

  7. Plasma glucagon

    Measured via blood collection

    Time frame: 3 hours

  8. Gastrointestinal symptoms

    Participants will be asked to rate how they are feeling on a scale of 0-10 (0 = no discomfort and 10 = very severe discomfort) on whether they feel nauseous, having any regurgitation, stomach fullness, experiencing any cramps and if they have an urge to defecate.

    Time frame: 3 hours

  9. Appetite

    To measure appetite (which will include being asked on hunger, fullness, satisfaction and prospective food consumption), participants will be shown a 100mm visual analog scale, which will have descriptors on both ends (e.g., I am not hungry at all, and I have never been hungrier in my life), and they will rate their appetite by drawing an intersecting vertical line along the horizontal line. The previous rating will be hidden to prevent the influence of a prior rating on the subsequent reporting.

    Time frame: 3 hours

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Mar 2026; primary completion for Dec 2026, 9 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2026
First posted
Mar 17, 2026
StartEst.
Mar 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Mar 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07476989
Lead sponsor
Manchester Metropolitan University
Collaborators
Cargill, The University of Bath
Responsible party
Sponsor
First posted
Mar 17, 2026
Start date
Mar 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Mar 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Fructose

Start the discussion